ONTX Onconova Therapeutics, Inc. - 8-K

Item 7.01 Regulation FD Disclosure.

On April 15, 2026, Traws Pharma, Inc. (the
“Company”) issued a press release (the “Earnings Release”) announcing its financial results for the fiscal year
ended December 31, 2025, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Current Report”)
and incorporated herein by reference.

The information set forth under
Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference
language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed
an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

Forward-Looking Statements

This Current Report, including
Exhibit 99.1, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms
“anticipates,” “expects,” “estimates,” “believes,” “will” and similar expressions,
as they relate to the Company or its management, are intended to identify such forward-looking statements.

Forward-looking statements in this Current Report,
including Exhibit 99.1, or hereafter, including in other publicly available documents filed with the Securities and Exchange Commission,
reports to the stockholders of the Company and other publicly available statements issued or released by the Company involve known and
unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance (financial or operating)
or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking
statements. Such future results are based upon management’s best estimates based upon current conditions and the most recent results
of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Securities
and Exchange Commission, each of which could adversely affect the Company’s business and the accuracy of the forward-looking statements
contained herein.

Item 9.01 Financial
Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

99.1

Press
Release, dated April 15, 2026

104

Cover
Page Interactive Data File (embedded within the inline XBRL Document)